Prostate Clinical Trials in Bethesda, Maryland
28 recruitingBethesda, Maryland
Showing 1–20 of 28 trials
Recruiting
Phase 3
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Prostate Cancer
AstraZeneca700 enrolled330 locationsNCT06952803
Recruiting
Phase 2
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Stage IV Renal Cell Cancer AJCC v8Stage IVB Prostate Cancer AJCC v8Large Cell Neuroendocrine Carcinoma+42 more
National Cancer Institute (NCI)314 enrolled578 locationsNCT03866382
Recruiting
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
Prostate CancerProstatic Neoplasms
National Cancer Institute (NCI)300 enrolled1 locationNCT01834001
Recruiting
Precision-Based Genomics in Prostate Cancer
Prostate Cancer
National Cancer Institute (NCI)2,000 enrolled11 locationsNCT04706663
Recruiting
Phase 2
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Metastatic Hormone Sensitive Prostate Cancer
Novartis Pharmaceuticals150 enrolled67 locationsNCT06991556
Recruiting
Collection of Blood From Patients With Prostate Cancer
Prostate CancerMetastatic Prostate CancerCancer of Prostate+2 more
National Cancer Institute (NCI)1,000 enrolled1 locationNCT00923221
Recruiting
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
Breast CancerLiver CancerProstate Cancer+2 more
National Cancer Institute (NCI)750 enrolled1 locationNCT00451022
Recruiting
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Head and Neck CarcinomaMalignant Solid NeoplasmSarcoma+59 more
Alliance for Clinical Trials in Oncology2,000 enrolled746 locationsNCT05334069
Recruiting
Phase 2
Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy
Prostate CancerRecurrent Prostate CancerPET Positive
National Cancer Institute (NCI)65 enrolled1 locationNCT06096870
Recruiting
Collection of Blood From Patients With Cancer
Breast CancerLiver CancerProstate Cancer+2 more
National Cancer Institute (NCI)1,750 enrolled1 locationNCT00034216
Recruiting
Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL
Prostate CancerBiochemically Recurrent
National Cancer Institute (NCI)350 enrolled1 locationNCT05588128
Recruiting
Phase 3
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Metastatic Prostate CarcinomaStage IVB Prostate Cancer AJCC v8Biochemically Recurrent Prostate Carcinoma+1 more
ECOG-ACRIN Cancer Research Group804 enrolled342 locationsNCT04423211
Recruiting
Phase 2
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast Carcinoma+28 more
National Cancer Institute (NCI)36 enrolled4 locationsNCT04550494
Recruiting
Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer
Prostate CancerProstatic CancerCancer of Prostate+2 more
National Cancer Institute (NCI)10,000 enrolled1 locationNCT03354416
Recruiting
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Breast CancerOvarian CancerProstate Cancer+2 more
National Cancer Institute (NCI)1,100 enrolled1 locationNCT01441089
Recruiting
Phase 3
Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents
Metastatic Castration-Sensitive Prostate Cancer
AstraZeneca1,800 enrolled410 locationsNCT06120491
Recruiting
Phase 1
Enzalutamide Implants (Enolen) in Patients With Prostate Cancer
Prostate Adenocarcinoma
Alessa Therapeutics Inc.56 enrolled7 locationsNCT06257693
Recruiting
Not Applicable
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer
Prostate CancerPolygenic Risk Score
Adam S. Kibel, MD1,500 enrolled5 locationsNCT06398639
Recruiting
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Breast CancerOvarian CancerEndometrial Cancer+40 more
Massive Bio, Inc.50,000 enrolled68 locationsNCT03452774
Recruiting
Hybrid Intelligence for Trustable Diagnosis and Patient Management of Prostate Cancer (HIT-PIRADS)
Prostate Cancer
Northwestern University800 enrolled1 locationNCT06804785